West Pharmaceutical Services, Inc. WST
- Market cap
- $26.3B
- P/E
- 47.1×
Follow WST
West Pharmaceutical Services, Inc. (WST) Debt to equity
West Pharmaceutical Services, Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 0.1×, up 0.0× from fiscal 2025 (0.1×). Over the past ten years it has ranged from 0.0× (fiscal 2023) to 0.2× (fiscal 2015); the current reading is higher than 18% of that period. That is below the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Annual
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.1× | (15.36%) |
| FY2024 | 0.1× | 198.42% |
| FY2023 | 0.0× | (67.14%) |
| FY2022 | 0.1× | (13.87%) |
| FY2021 | 0.1× | (34.46%) |
| FY2020 | 0.1× | (15.85%) |
| FY2019 | 0.2× | 15.46% |
| FY2018 | 0.1× | (8.77%) |
| FY2017 | 0.2× | (23.96%) |
| FY2016 | 0.2× | (9.48%) |
Quarterly
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 0.1× | 0.15% |
| Mar 2026 | 0.1× | 6.10% |
| Dec 2025 | 0.1× | (3.77%) |
| Sep 2025 | 0.1× | (4.05%) |
| 42 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| RMD ResMed Inc. compare | 0.1× |
| WST West Pharmaceutical Services, Inc. | 0.1× |
| ALC Alcon compare | 0.2× |
| RGEN Repligen Corporation compare | 0.3× |
| COO The Cooper Companies, Inc. compare | 0.3× |
| BDX Becton, Dickinson and Company compare | 0.6× |
| MDLN Medline Inc. compare | 0.7× |
| SOLV Solventum Corporation compare | 1.1× |
| BAX Baxter International Inc. compare | 1.5× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.2× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on WST
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement